Shanghai, China

Jingquan Ye


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jingquan Ye: Innovator in Pharmaceutical Chemistry

Introduction

Jingquan Ye is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on phenylpropionamide derivatives. His research has implications for clinical treatments, showcasing the importance of stability in pharmaceutical compounds.

Latest Patents

Jingquan Ye holds a patent for a salt of phenylpropionamide derivative and its preparation method. This patent describes a salt of a compound that exhibits good stability, making it suitable for clinical applications. The preparation process for this compound is noted for its simplicity and ease of operation, which enhances its potential for practical use in the medical field.

Career Highlights

Throughout his career, Jingquan Ye has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. These experiences have allowed him to apply his innovative ideas in real-world settings, contributing to advancements in medicine.

Collaborations

Jingquan Ye has collaborated with several professionals in his field, including Wei Zhang and Qiyun Shao. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Jingquan Ye's contributions to pharmaceutical chemistry, particularly through his patent on phenylpropionamide derivatives, highlight his role as an innovator in the industry. His work not only advances scientific knowledge but also has the potential to improve clinical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…